NANOTECHNOLOGY REPORT
March 1st, 2005
BY KEITH NUTHALLPHARMACEUTICAL companies have been accused of risking missing the opportunities offered by the latest technological zeitgeist, that of nanotechnology. Consultants Lux Research has warned that while European Union (EU) governments are spending on nanotechnology research, large medicine manufacturers are investing very little. Its report "Why big pharma is missing the nanotech opportunity" claims that this failure could expose the sector to strategic risks, with other industries dominating this emerging technology. Indeed, Lux claim nanotechnology ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.